Vertex Pharmaceuticals (VRTX) Interest Coverage Ratio (2009 - 2025)
Vertex Pharmaceuticals (VRTX) recorded quarterly Interest Coverage Ratio of 365.42 in Q4 2025, up 1.66% quarter-over-quarter from 359.45 in Q3 2025, and little changed on a YoY basis from 366.43 in Q4 2024.
Vertex Pharmaceuticals (VRTX) Interest Coverage Ratio (2009 - 2025) Analysis & Trends
Vertex Pharmaceuticals' Interest Coverage Ratio history runs 10 years deep, the most recent figure standing at 365.42 for Q4 2025.
- In Q4 2025, Interest Coverage Ratio changed 0.27% year-over-year to 365.42; the TTM figure through Mar 2026 stood at 454.5 (up 1520.49% YoY), while the FY2025 annual figure was 313.78, up 4222.68% from the prior year.
- Interest Coverage Ratio was 365.42 for Q4 2025 at Vertex Pharmaceuticals, up from 359.45 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 366.43 in Q4 2024 to a low of 355.02 in Q2 2024.
- Historically, Interest Coverage Ratio has averaged 163.27 across 3 years, with a median of 148.84 in 2024.
- Biggest YoY gain for Interest Coverage Ratio was 292.93% in 2024; the steepest drop was 487.4% in 2024.
- A 3-year view of Interest Coverage Ratio shows it stood at 93.25 in 2023, then jumped by 292.93% to 366.43 in 2024, then fell by 0.27% to 365.42 in 2025.
- The last three Interest Coverage Ratio figures came in at 365.42 (Q4 2025), 359.45 (Q3 2025), and 311.11 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 49.84 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 365.42 |
| Sep 30, 2025 | 359.45 |
| Jun 30, 2025 | 311.11 |
| Mar 31, 2025 | 210.03 |
| Dec 31, 2024 | 366.43 |
| Sep 30, 2024 | 148.84 |
| Jun 30, 2024 | -355.02 |
| Mar 31, 2024 | 109.57 |
| Dec 31, 2023 | 93.25 |
| Sep 30, 2023 | 95.24 |
| Jun 30, 2023 | 91.64 |
| Dec 31, 2020 | 45.79 |
| Sep 30, 2020 | 48.52 |
| Jun 30, 2020 | 51.77 |
| Mar 31, 2020 | 50.95 |
| Dec 31, 2019 | 38.70 |
| Sep 30, 2019 | 6.83 |
| Jun 30, 2019 | 18.20 |
| Mar 31, 2019 | 18.62 |
| Dec 31, 2018 | 6.81 |